Correlation Between Wealthsimple Shariah and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Wealthsimple Shariah and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wealthsimple Shariah and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wealthsimple Shariah World and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Wealthsimple Shariah and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wealthsimple Shariah with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wealthsimple Shariah and Acumen Pharmaceuticals.
Diversification Opportunities for Wealthsimple Shariah and Acumen Pharmaceuticals
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Wealthsimple and Acumen is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Wealthsimple Shariah World and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Wealthsimple Shariah is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wealthsimple Shariah World are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Wealthsimple Shariah i.e., Wealthsimple Shariah and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Wealthsimple Shariah and Acumen Pharmaceuticals
Assuming the 90 days trading horizon Wealthsimple Shariah World is not expected to generate positive returns. However, Wealthsimple Shariah World is 9.64 times less risky than Acumen Pharmaceuticals. It waists most of its returns potential to compensate for thr risk taken. Acumen Pharmaceuticals is generating about 0.06 per unit of risk. If you would invest 141.00 in Acumen Pharmaceuticals on August 20, 2025 and sell it today you would earn a total of 17.00 from holding Acumen Pharmaceuticals or generate 12.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.41% |
| Values | Daily Returns |
Wealthsimple Shariah World vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Wealthsimple Shariah |
| Acumen Pharmaceuticals |
Wealthsimple Shariah and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Wealthsimple Shariah and Acumen Pharmaceuticals
The main advantage of trading using opposite Wealthsimple Shariah and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wealthsimple Shariah position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Wealthsimple Shariah vs. Wealthsimple North America | Wealthsimple Shariah vs. Wealthsimple Developed Markets | Wealthsimple Shariah vs. Wealthsimple North American | Wealthsimple Shariah vs. NBI High Yield |
| Acumen Pharmaceuticals vs. Inovio Pharmaceuticals | Acumen Pharmaceuticals vs. Opus Genetics, | Acumen Pharmaceuticals vs. Agenus Inc | Acumen Pharmaceuticals vs. Alector |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |